Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600 stock index to a … Read more

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces  billion deal

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Bristol Myers Squibb on Nov. 20th, 2020. NYSE Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47% on the news … Read more

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE It’s encouraging to see three Club stocks on the bullish side of Goldman Sachs’ new list of 25 tactical trades for earnings season. Asset allocation can be strategic or tactical. Strategic asset allocation generally refers to longer-term investing — think of this as your buy-and-hold approach. … Read more

Johnson & Johnson investors may soon swap their shares for Kenvue stock — here’s what you need to know

Johnson & Johnson investors may soon swap their shares for Kenvue stock — here’s what you need to know

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc., a Johnson & Johnson consumer health company, pose together during the company’s IPO on the New York Stock Exchange (NYSE) in New York, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson said Thursday … Read more

Pfizer will raise a $31 billion debt offering to finance its purchase of Seagen, SEC filings show

Pfizer will raise a  billion debt offering to finance its purchase of Seagen, SEC filings show

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The logo for Pfizer is displayed on a monitor on the floor of the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to finance your proposed acquisition manufacturer of anti-cancer drugs Seagenfor which … Read more

Club meeting recap: Jim Cramer says Johnson & Johnson’s post-earnings sell-off is a mistake and a buying opportunity

Club meeting recap: Jim Cramer says Johnson & Johnson’s post-earnings sell-off is a mistake and a buying opportunity

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Every weekday, the CNBC Investing Club with Jim Cramer hosts “The Morning Briefing” live at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow Falls, Profits in Focus J & J Declines Missed Starbucks Undervalued? 1. Dow falls with earnings taking center stage Stocks … Read more

;
error: Content is protected !!